公开(公告)号：EP1685102A4

公开(公告)日：2008-08-20

申请号：EP04800082

申请日：2004-11-12

申请人： LG LIFE SCIENCES LTD ,  YAMANOUCHI PHARMA CO LTD

发明人： LEE KOO ,  PARK HEUI-SUL ,  AHN IN-AE ,  YOO HYUN-JU ,  KIM JONG-YUP ,  CHOI DEOG-YOUNG ,  YIM HYEON-JOO ,  CHUNG KYUNG-HA ,  SHIM DONG-SUP ,  LEE SANG-KYUN ,  KONDOH YUTAKA ,  HIRABAYASHI RYOJI ,  HONDA SHUGO ,  KAKU HIDETAKA ,  SHISHIKURA JUN-ICHI ,  ITO HIROYUKI ,  KURAMA TAKESHI

IPC分类号： C07D205/04 ,  A61K31/397 ,  A61P3/00 ,  A61P15/10 ,  C07D207/14 ,  C07D207/16 ,  C07D211/58 ,  C07D401/12 ,  C07D403/12 ,  C07D405/12

CPC分类号： C04B35/632 ,  C07D205/04 ,  C07D207/14 ,  C07D211/58 ,  C07D401/12 ,  C07D403/12 ,  C07D405/12

摘要： The present invention relates a compound of formula 1, and pharmaceutically acceptable salt, hydrate, solvate, or isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.